The distributions of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 allele and haplotype at high‐resolution level in Zhejiang Han population of China
International Journal of Immunogenetics · 2019-02 · 46 (1) · 7-16
DOI: 10.1111/iji.12411 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, online erschienen am 28.12.2018. Verfasst von Nanying Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Science Research Foundation of Zhejiang Province, Science Research Foundation of Zhejiang Healthy Bureau.
Abstract (Originalsprache)
The distributions of HLA allele and haplotype are variable in different ethnic populations and the data for some populations have been published. However, the data on HLA‐C and HLA‐DQB1 loci and the haplotype of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 loci at a high‐resolution level are limited in Zhejiang Han population, China. In this study, the frequencies of the HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 loci and haplotypes were analysed among 3,548 volunteers from the Zhejiang Han population using polymerase chain reaction sequencing‐based typing method. Totals of 51 HLA‐A, 97 HLA‐B, 45 HLA‐C, 53 HLA‐DRB1 and 27 HLA‐DQB1 alleles were observed. The top three frequent alleles of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 loci were A*11:01 (23.83%), A*24:02 (17.16%), A*02:01 (11.36%); B*40:01 (14.08%), B*46:01 (12.20%), B*58:01 (8.50%); C*07:02 (18.25%), C*01:02:01G (18.15%), C*03:04 (9.88%); DRB1*09:01 (17.52%), DRB1*12:02 (10.57%), DRB1*15:01 (9.70%); DQB1*03:01 (22.63%), DQB1*03:03 (18.26%) and DQB1*06:01 (10.88%), respectively. A total of 141 HLA‐A‐C‐B‐DRB1‐DQB1 haplotypes with a frequency of ≥0.1% were found and the haplotypes with frequency greater than 3% were A*02:07‐C*01:02:01G‐B*46:01‐DRB1*09:01‐DQB1*03:03 (4.20%), A*33:03‐C*03:02‐B*58:01‐DRB1*03:01‐DQB1*02:01 (4.15%), A*30:01‐C*06:02‐B*13:02‐DRB1*07:01‐DQB1*02:02 (3.20%). The likelihood ratios test for the linkage disequilibrium of two loci haplotypes was revealed that the majority of the pairwise associations were statistically significant. The data presented in this study will be useful for searching unrelated HLA‐matched donor, planning donor registry and for anthropology studies in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Blood Center of Zhejiang Province, Hangzhou, China.
- Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Faming Zhu
Förderung
- Science Research Foundation of Zhejiang Province
- Science Research Foundation of Zhejiang Healthy Bureau
Zitieren
APA
Chen, N., Wang, W., Wang, F., Dong, L., Zhao, S., Zhang, W., He, J., Huang, H., & Zhu, F. (2019). The distributions of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 allele and haplotype at high‐resolution level in Zhejiang Han population of China. International Journal of Immunogenetics, 46(1), 7-16. https://doi.org/10.1111/iji.12411
Vancouver
Chen N, Wang W, Wang F, Dong L, Zhao S, Zhang W, et al. The distributions of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 allele and haplotype at high‐resolution level in Zhejiang Han population of China. International Journal of Immunogenetics. 2019;46(1):7-16. doi:10.1111/iji.12411
BibTeX
@article{Chen2019,
author = {Chen, Nanying and Wang, Wei and Wang, Fang and Dong, Lina and Zhao, Shuoxian and Zhang, Wei and He, Ji and Huang, He and Zhu, Faming},
title = {The distributions of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 allele and haplotype at high‐resolution level in Zhejiang Han population of China},
journal = {International Journal of Immunogenetics},
year = {2019},
volume = {46},
number = {1},
pages = {7--16},
doi = {10.1111/iji.12411}
}
EUVIMED